IVERIC bio (ISEE) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P dip, trading choppy as tech stocks fall
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Iveric Bio Reports Third Quarter 2022 Operational Highlights and Financial Results
November 3, 2022 6:30 AM EDT- Reported Positive GATHER2 Results for Avacincaptad Pegol in Geographic Atrophy -
- Planned NDA Submission Moved Up to End of This Year -
- Received Favorable Feedback from FDA on Intermediate AMD Development Plan -
- Conference Call and Webcast Today, November 3, 2022, at 8:00 a.m. ET -
PARSIPPANY, N.J.--(BUSINESS... More
